3,4-Methylenedioxyethylamphetamine (MDE), a novel analogue of MDMA, produces long-lasting depletion of serotonin in the rat brain

Eur J Pharmacol. 1987 Jun 4;137(2-3):265-8. doi: 10.1016/0014-2999(87)90233-0.

Abstract

The present study was carried out to asses possible toxic effects of 3,4-methylenedioxyethylamphetamine (MDE) on serotonergic, dopaminergic or noradrenergic neurons in the rat brain. It was found that MDE produced a long-lasting, dose-related depletion of serotonin (5HT). However, even at high dosage, MDE did not reduce the concentration of either dopamine (DA) or norepinephrine (NE) on a long-term basis. When compared to 3,4-methylenedioxymethylamphetamine (MDMA), MDE was approximately one fourth as potent as producing a long-term depletion of 5HT. These results suggest that MDE, like MDMA, may be selectively toxic to central serotonergic neurons.

MeSH terms

  • 3,4-Methylenedioxyamphetamine / analogs & derivatives
  • 3,4-Methylenedioxyamphetamine / pharmacology*
  • Amphetamines / pharmacology*
  • Animals
  • Brain / drug effects
  • Brain / metabolism*
  • Dopamine / metabolism
  • Dose-Response Relationship, Drug
  • Male
  • N-Methyl-3,4-methylenedioxyamphetamine
  • Norepinephrine / metabolism
  • Rats
  • Rats, Inbred Strains
  • Serotonin / metabolism*

Substances

  • Amphetamines
  • Serotonin
  • 3,4-Methylenedioxyamphetamine
  • N-Methyl-3,4-methylenedioxyamphetamine
  • 3,4-methylenedioxyethamphetamine
  • Dopamine
  • Norepinephrine